Robert Solenne, Diagbouga Potiandi Serge, Djibougou Arthur Diakourga, Guy Danielle, Bagnall Robert, Ravel Fanette
Global Medical Affairs, bioMérieux SA, Marcy l'Etoile, France.
Institut de Recherche en Sciences de la Santé (IRSS), Centre National de la Recherche Scientifique et Technologique (CNRST), Ouagadougou, Burkina Faso.
PLoS Negl Trop Dis. 2025 Jun 30;19(6):e0013196. doi: 10.1371/journal.pntd.0013196. eCollection 2025 Jun.
Dengue is a re-emerging infectious disease that poses substantial challenges to healthcare systems in endemic regions, such as West Africa. Owing to its nonspecific and overlapping clinical symptoms - including fever, rash, headache, joint pains, nausea, vomiting - many cases go unrecognized or are misdiagnosed. Consequently, patients are often inappropriately treated with antimalarial or antibiotic therapies. Such mismanagement not only affects patient outcomes but also contributes to the development of antimicrobial and antimalarial drug resistance within these populations. This literature review aimed to describe the patterns and impact of dengue diagnosis in West Africa.
A comprehensive electronic database search of MEDLINE and Embase was conducted using keywords related to dengue, chikungunya, acute febrile illness, diagnostic strategies, and clinical management. Additional manual searches was performed through Google Scholar and relevant conference proceedings. Eligible studies included observational, real-world evidence, or interventional research conducted in West Africa involving adult patients diagnosed with dengue or chikungunya. Inclusion criteria required studies to report on diagnostic approaches and/or clinical management strategies. Due to the limited availability of data on chikungunya, this review focused exclusively on dengue.
Ten studies from Burkina Faso, Ivory Coast, Senegal, and Nigeria were included in this review. Rapid serologic testing (DENGUE NS1, IgG, IgM) was the most frequently used diagnostic tools, used in 60% of the studies. Clinical management of dengue primarily involved the administration of antipyretics, fluid therapy, and blood transfusions when necessary. In five studies, antimalarial treatments were systematically prescribed despite negative malaria results. Additionally, two studies reported the use of antibiotics without confirmed bacterial infection or supporting biological diagnosis, indicating inappropriate antibiotic use.
Evidence on dengue diagnosis and related clinical management in West Africa remains limited. The available data indicate a widespread underuse of diagnosis tools and frequent misuse of antimalarial and antibiotic therapies in the management of dengue. Future studies should prioritize evaluating the impact of accurate differential diagnosis between dengue and malaria on patient care, particularly regarding the inappropriate use of antibiotics and antimalarials. Moreover, integrating routine diagnostic testing into standard clinical practice, as recommended by health authorities, could significantly improve current management. This would enable clinicians to more accurately diagnose dengue, malaria, other febrile illnesses, and potential co-infections, ultimately reducing the misuse of antimicrobial treatments.
登革热是一种再度流行的传染病,给西非等流行地区的医疗系统带来了巨大挑战。由于其非特异性且相互重叠的临床症状,包括发热、皮疹、头痛、关节疼痛、恶心、呕吐,许多病例未被识别或被误诊。因此,患者常常接受不恰当的抗疟或抗生素治疗。这种管理不善不仅影响患者的治疗结果,还导致这些人群中抗菌药物和抗疟药物耐药性的发展。这篇文献综述旨在描述西非登革热诊断的模式和影响。
使用与登革热、基孔肯雅热、急性发热性疾病、诊断策略和临床管理相关的关键词,对MEDLINE和Embase进行全面的电子数据库检索。通过谷歌学术和相关会议论文集进行了额外的手动检索。符合条件的研究包括在西非进行的涉及诊断为登革热或基孔肯雅热的成年患者的观察性、真实世界证据或干预性研究。纳入标准要求研究报告诊断方法和/或临床管理策略。由于基孔肯雅热的数据有限,本综述仅关注登革热。
本综述纳入了来自布基纳法索、科特迪瓦、塞内加尔和尼日利亚的10项研究。快速血清学检测(登革热NS1、IgG、IgM)是最常用的诊断工具,60%的研究中使用了该工具。登革热的临床管理主要包括必要时给予退烧药、液体疗法和输血。在五项研究中,尽管疟疾检测结果为阴性,但仍系统性地开具了抗疟治疗药物。此外,两项研究报告在未确认细菌感染或无生物学诊断支持的情况下使用了抗生素,表明存在抗生素使用不当的情况。
西非关于登革热诊断及相关临床管理的证据仍然有限。现有数据表明,在登革热管理中,诊断工具的使用普遍不足,抗疟和抗生素治疗经常被滥用。未来的研究应优先评估登革热和疟疾准确鉴别诊断对患者护理的影响,特别是关于抗生素和抗疟药的不当使用。此外,按照卫生当局的建议,将常规诊断检测纳入标准临床实践,可以显著改善当前的管理。这将使临床医生能够更准确地诊断登革热、疟疾、其他发热性疾病以及潜在的合并感染,最终减少抗菌治疗的滥用。